NDC 83257-003 – Ogivri

Trastuzumab 420 mg/20mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC83257-003

Product details

Brand name
Ogivri
Generic name
Trastuzumab-dkst
Labeler
Biocon Biologics Inc.
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
BLA · BLA761074
Marketed since
October 1, 2023
Listing expires
December 31, 2027
Pharmacologic class
HER2/neu Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ogivri →

Package NDC codes (0)

Package NDCDescriptionSince

Other Ogivri products